AC8
Pharmaceuticals, Biotechnology & Life Sciences
Auscann Group Holdings
- Short interest
- 0.01%
- 0.00 pp 30d
- as of 21 Feb 2022
- Reported shorts
- 50.9K
- Shares on issue
- 440.547M
Auscann Group Holdings (AC8) financials
Results, ratios and statements
Fundamentals
Our data providers hold no financial statements for AC8 (last checked 14 Oct 2026). The company's own filings are listed below.
Financial reports
The company's own filings, newest first